Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Michael O'grady is Chairman and CEO at Northern Trust. OQRO lists 11 transactions filed with the SEC under this name, the latest on Nov 5, 2026, each linked to the official Form 4.
Chairman and CEO
Disclosures on record
11
Companies involved
2
Michael O'grady bought shares on the open market in 2023, and has not bought since 2023. Sales in 1 of the 6 years since 2021.
Michael O'grady reported 1 open-market purchase and 4 sales since 2021; purchases in 2023.
| Year | Bought | Sold |
|---|---|---|
| 2023 | $1.3M1×1 trade | — |
| 2021 | — | $17.1M4×4 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Northern TrustNTRS
9 disclosures · Dec 2025 – Nov 2026
Nov 3, 2026787disclosed Nov 5
DetailsOfficial recordMar 1, 202611Kdisclosed Mar 5
DetailsOfficial recordFeb 17, 202673Kdisclosed Feb 19
DetailsOfficial recordFeb 17, 202632Kdisclosed Feb 19
DetailsOfficial recordFeb 5, 202619Kdisclosed Feb 10
DetailsOfficial recordJan 29, 202634Kdisclosed Feb 2
DetailsOfficial recordJan 29, 202634Kdisclosed Feb 2
DetailsOfficial recordJan 29, 202622Kdisclosed Feb 2
DetailsOfficial recordDec 3, 2025770disclosed Dec 5
DetailsOfficial recordAbbott LaboratoriesABT
2 disclosures · Apr 2026
Apr 24, 20262,286disclosed Apr 28
DetailsOfficial recordApr 24, 20265,929disclosed Apr 28
DetailsOfficial recordAs of the latest filing on , Michael O'grady reported holding 417,928 shares of Northern Trust (NTRS), worth about $74.5M at the last close of $178 (Nov 13, 2026): 56,110 held directly and 361,818 through a trust. Holdings are also on file at Abbott Laboratories (ABT); together they are worth about $75.3M.
Northern Trust's proxy statement reports total compensation of $10.1M for Michael O'grady for fiscal year 2025, after $10.9M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed Mar 11, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Northern Trust NTRS | 417,928 | 56K direct · 362K trust | $178 | $74.5M | Nov 3, 2026 |
| Abbott Laboratories ABT | 7,603 | 7,603 direct | $109 | $825K | Apr 24, 2026 |
Is this Michael O'grady’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Nov 3, 2026, Michael O'grady reported holding 417,928 shares of Northern Trust (NTRS), of which 361,818 are held indirectly. At the last close of $178 on Nov 13, 2026, that is about $74.5M. This is the stake disclosed in filings, not a net worth.
Northern Trust's proxy statement reports total compensation of $10.1M for Michael O'grady for fiscal year 2025, after $10.9M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.
Michael O'grady bought shares on the open market in 2023, and has not bought since 2023. Sales in 1 of the 6 years since 2021.
In SEC filings since 2021: the latest open-market purchase is from 2023; the latest open-market sale is from 2021.
Northern Trust (NTRS), from 2021 to 2023: 1 purchase and 4 sales.
Michael O'grady reported 1 open-market purchase and 4 sales here, 2021 to 2023.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
